User:Z5088434

--Mark Hill (talk) 17:16, 5 August 2015 (AEST) Well done, you were first! We will be talking more about this in the Practical on Friday.

Please do not use your real name on this website, use only your student number.

2015 Course: Week 2 Lecture 1 Lecture 2 Lab 1 | Week 3 Lecture 3 Lecture 4 Lab 2 | Week 4 Lecture 5 Lecture 6 Lab 3 | Week 5 Lecture 7 Lecture 8 Lab 4 | Week 6 Lecture 9 Lecture 10 Lab 5 | Week 7 Lecture 11 Lecture 12 Lab 6 | Week 8 Lecture 13 Lecture 14 Lab 7 | Week 9 Lecture 15 Lecture 16 Lab 8 | Week 10 Lecture 17 Lecture 18 Lab 9 | Week 11 Lecture 19 Lecture 20 Lab 10 | Week 12 Lecture 21 Lecture 22 Lab 11 | Week 13 Lecture 23 Lecture 24 Lab 12 | 2015 Projects: Three Person Embryos | Ovarian Hyper-stimulation Syndrome | Polycystic Ovarian Syndrome | Male Infertility | Oncofertility | Preimplantation Genetic Diagnosis | Students | Student Designed Quiz Questions | Moodle page

Glossary Links

Glossary: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Numbers | Symbols | Term Link

Lab Attendance

--Z5088434 (talk) 13:46, 7 August 2015 (AEST)

Test student 2015

Lab 1 - Online Assessment

Summary of Article I: PMID 26193891

Aim: -study impact of low-dose growth hormone (GH) supplementation for patients with poor ovarian response (POR) in IVF -GH participates in follicular development by regulating gonadotropins in granulosa cells by regulating synthesis of IGF-I--> plays important role in synthesis of sex steroids and oocyte maturation -GH has been in use since 1990s for IVF but showed mixed results, therapeutic advantages only in women of advanced reproductive age -GH dose in IVF supplementation is same as commonly used in patients with GH-deficiency, but POR patients are not GH-deficient --> lower dose

Method:

Results:

References

PMID 26193891